Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William H Herman

Showing results (61-70 of 354) with videos related to

Pageof 36
Sort By:
Diabetes Care|May 22, 2019
Response to Comment on Evron et al. Changes in Screening Practices for Prediabetes and Diabetes Since the Recommendation for Hemoglobin A<sub>1c</sub> Testing. Diabetes Care 2019;42:576-584Joshua M Evron, William H Herman, Laura N McEwen
Metabolism: Clinical and Experimental|August 21, 2010
Insufficient sensitivity of hemoglobin A(₁C) determination in diagnosis or screening of early diabetic statesStefan S Fajans, William H Herman, Elif A Oral
American Journal of Therapeutics|December 1, 1995
Cyclic AMP-Independent Mechanisms of Nuclear Signal Transduction by PGE(2)Michael S. Simonson, William H. Herman, Michael J. Dunn
Diabetes Care|February 23, 2017
Comment on Hofer et al. International Comparison of Smoking and Metabolic Control in Patients With Type 1 Diabetes. Diabetes Care 2016;39:e177-e178Beverley Balkau, Soraya Soulimane, Dominique Simon, et al.
Diabetes Care|January 29, 2005
The efficacy and cost of alternative strategies for systematic screening for type 2 diabetes in the U.S. population 45-74 years of ageSusan L Johnson, Bahman P Tabaei, William H Herman
Diabetes Care|October 15, 2016
Reconciliation of Type 2 Diabetes Remission Rates in Studies of Roux-en-Y Gastric BypassDeanna J M Isaman, Amy E Rothberg, William H Herman
Diabetes Technology & Therapeutics|July 30, 2015
The Michigan Model for Coronary Heart Disease in Type 2 Diabetes: Development and ValidationWen Ye, Michael Brandle, Morton B Brown, et al.
Diabetes Care|May 21, 2021
The Effectiveness of a Proactive, Three-Level Strategy to Identify People With Prediabetes in a Large Workforce With Employer-Sponsored Health InsuranceWilliam H Herman, Kevin Joiner, Thomas Hurst, et al.
Journal of Diabetes and Its Complications|March 4, 2011
The effort required to achieve and maintain optimal glycemic controlElyse S Rosenthal, Eran Bashan, William H Herman, et al.
Statistics in Medicine|January 18, 2006
A discrete-state discrete-time model using indirect observationDeanna J M Isaman, William H Herman, Morton B Brown
Pageof 36

Showing results (61-70 of 354) with videos related to

Sort By:
Pageof 36
Diabetes Care|May 22, 2019
Response to Comment on Evron et al. Changes in Screening Practices for Prediabetes and Diabetes Since the Recommendation for Hemoglobin A<sub>1c</sub> Testing. Diabetes Care 2019;42:576-584Joshua M Evron, William H Herman, Laura N McEwen
Metabolism: Clinical and Experimental|August 21, 2010
Insufficient sensitivity of hemoglobin A(₁C) determination in diagnosis or screening of early diabetic statesStefan S Fajans, William H Herman, Elif A Oral
American Journal of Therapeutics|December 1, 1995
Cyclic AMP-Independent Mechanisms of Nuclear Signal Transduction by PGE(2)Michael S. Simonson, William H. Herman, Michael J. Dunn
Diabetes Care|February 23, 2017
Comment on Hofer et al. International Comparison of Smoking and Metabolic Control in Patients With Type 1 Diabetes. Diabetes Care 2016;39:e177-e178Beverley Balkau, Soraya Soulimane, Dominique Simon, et al.
Diabetes Care|January 29, 2005
The efficacy and cost of alternative strategies for systematic screening for type 2 diabetes in the U.S. population 45-74 years of ageSusan L Johnson, Bahman P Tabaei, William H Herman
Diabetes Care|October 15, 2016
Reconciliation of Type 2 Diabetes Remission Rates in Studies of Roux-en-Y Gastric BypassDeanna J M Isaman, Amy E Rothberg, William H Herman
Diabetes Technology & Therapeutics|July 30, 2015
The Michigan Model for Coronary Heart Disease in Type 2 Diabetes: Development and ValidationWen Ye, Michael Brandle, Morton B Brown, et al.
Diabetes Care|May 21, 2021
The Effectiveness of a Proactive, Three-Level Strategy to Identify People With Prediabetes in a Large Workforce With Employer-Sponsored Health InsuranceWilliam H Herman, Kevin Joiner, Thomas Hurst, et al.
Journal of Diabetes and Its Complications|March 4, 2011
The effort required to achieve and maintain optimal glycemic controlElyse S Rosenthal, Eran Bashan, William H Herman, et al.
Statistics in Medicine|January 18, 2006
A discrete-state discrete-time model using indirect observationDeanna J M Isaman, William H Herman, Morton B Brown
Pageof 36